Raymond James Begins Coverage of Accelerant Holdings with an Outperform Rating and Sets Price Target at $33
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 18 2025
0mins
Source: Benzinga
Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders to stay updated on market movements.
Exclusive Content: The platform provides exclusive stories and insights generated by Benzinga reporters.
Community Engagement: Over 10,000 serious traders are part of the Benzinga Pro community, sharing strategies and intelligence.
Market Winning Tool: Traders utilize Benzinga Pro's resources to enhance their trading success in the stock market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ARX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ARX
Wall Street analysts forecast ARX stock price to rise
9 Analyst Rating
7 Buy
2 Hold
0 Sell
Strong Buy
Current: 12.840
Low
17.00
Averages
19.62
High
24.48
Current: 12.840
Low
17.00
Averages
19.62
High
24.48
About ARX
Accelerant Holdings is engaged in transforming specialty insurance through advanced data analytics, AI-driven insights, and innovation. It operates a data-driven risk exchange that connects selected specialty insurance underwriters (the Sellers on its platform) with risk capital partners (the Buyers on its platform). Its Risk Exchange reduces information asymmetries and operational barriers present in the traditional insurance value chain by leveraging proprietary technology to share actionable high-fidelity data and insights with platform participants. Its segments include Exchange Services, MGA Operations, and Underwriting. The Exchange Services segment is its core business, its Risk Exchange- the Accelerant technology, data ingestion, and agency operations that serve the needs of its members and risk capital partners. Its technology-powered platform addresses these issues by connecting specialty underwriters, typically managing general agents (MGAs), and risk capital partners.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Shareholder Support: Independent advisory firms ISS and Glass Lewis have recommended that ARC Resources shareholders vote 'FOR' the arrangement resolution at the special meeting on July 14, 2026, reflecting confidence in the company's future and expected enhancement of shareholder returns.
- Arrangement Details: Under the arrangement agreement, ARC shareholders are entitled to receive 0.40247 of a Shell ordinary share and $8.20 in cash per ARC share, totaling $32.80 per share, representing a 27.3% premium over the unaffected trading price as of April 24, 2026, providing immediate liquidity and certainty of value for shareholders.
- Expected Synergies: The combined company is anticipated to achieve annual synergies of $250 million, which will not only strengthen its financial position but also enhance its competitive edge in the market, driving long-term growth.
- Voting Deadline: ARC shareholders are encouraged to vote 'FOR' the arrangement resolution before the proxy voting deadline of July 10, 2026, ensuring a smooth passage of the arrangement at the upcoming meeting, thereby laying a solid foundation for the company's future development.
See More
- Partnership Enhancement: Accelerant has announced an enhanced partnership with Lloyd's of London by launching the ARX Consortium, supported by seven respected Lloyd's syndicates, aiming to establish a flexible platform for a diversified specialty risk portfolio that leverages high-quality premium flow and the reputation of the Lloyd's Market.
- Risk Exchange Platform: The ARX Risk Exchange connects specialty insurance underwriters with risk capital providers through advanced analytics, real-time data, and transparent underwriting insights, supporting diversified, low-volatility premium performance and enhancing market competitiveness.
- Mission to Modernize: Accelerant's mission is to modernize the specialty insurance marketplace, focusing on improving underwriting efficiency through data-driven solutions, thereby providing profitable growth to Lloyd's and reinforcing its unique position in the global specialty insurance domain.
- Expanding MGA Membership: CEO Jeff Radke stated that as the group of MGA Members expands, Accelerant will deliver sustainable profitable growth to Lloyd's, showcasing the deep collaborative potential between the two in the specialty insurance market.
See More
- Share Sale Details: Francis James O’Neill, Co-Founder and Chief Underwriting Officer of Accelerant Holdings, indirectly sold 147,000 shares between June 25 and 26, 2026, generating approximately $1.93 million at a weighted average price of $13.12 per share, reflecting confidence in the market.
- Ownership Analysis: The 147,000 shares sold represented only 2.04% of O’Neill's total holdings, as he retains 6,903,125 shares indirectly and 166,644 shares directly, indicating that the transaction has a minimal impact on his overall investment portfolio, alleviating investor concerns.
- Financial Performance: Although Accelerant posted a significant net loss in 2025, the adjusted earnings for Q1 2026 more than doubled year-over-year to $0.17 per share after accounting for non-recurring expenses, demonstrating an improvement in profitability.
- Buyback Plan and Growth Potential: The company's board has authorized a share repurchase program of up to $200 million, and the first quarter saw a 16% year-over-year increase in exchange written premiums to $1.14 billion, indicating strong growth potential in the small and medium commercial client market.
See More
- Insider Selling Details: Francis James O’Neill, Co-Founder and Chief Underwriting Officer of Accelerant Holdings, sold 147,000 shares between June 25 and 26, 2026, for an estimated total of $1.93 million, impacting 2.04% of his indirect holdings, which indicates his continued confidence in the company's future.
- Historical Trade Comparison: This sale aligns with O’Neill's recent trading pattern, marking the second consecutive sale of 147,000 shares, demonstrating consistency and stability in his market operations without affecting his direct ownership.
- Indirect Ownership Analysis: Post-transaction, O’Neill retains 6,903,125 shares indirectly and 166,644 shares directly, maintaining a significant investment in Accelerant Holdings, reflecting his ongoing focus on the company's performance.
- Company Financial Overview: With a market capitalization of $2.76 billion, Accelerant Holdings reported a net loss of $1.36 billion in 2025; however, adjusted earnings for the first quarter more than doubled year-over-year to $0.17 per share, indicating a path toward profitability and promising growth potential ahead.
See More
- Partnership Expansion: Incline P&C Group has announced an enhanced partnership with Accelerant, serving as a fronting carrier for over $500 million in annual gross written premiums across Accelerant's U.S. commercial specialty insurance portfolio, further solidifying its position in the specialty insurance market.
- Growth Potential: This collaboration will increase Incline's participation in Accelerant's high-quality specialty insurance portfolio and provide direct reinsurance access to its Risk Capital Partners, which is expected to drive profitable growth for both parties.
- Customer Focus: Incline's CEO Chris McClellan emphasized that the partnership will continue to support Managing General Agents (MGAs) and their clients, enhancing customer experience and promoting sustainable market development.
- Industry Leadership: Since its founding in 2015, Incline has established itself as a leading service provider in the specialty insurance market, leveraging strong risk management and underwriting capabilities, with a team of over 100 employees showcasing its leadership in the industry.
See More

- Enhanced Partnership: Hippo's collaboration with Accelerant enables the company to achieve over $500 million in annual gross written premiums in 2027, aiming for a $2 billion target a year ahead of schedule, showcasing strong growth potential in the specialty insurance market.
- Financial Guidance Update: Hippo has revised its 2028 financial guidance, projecting gross written premiums of $2.5 billion and adjusted net income of $140 million, both up from previous estimates of $2 billion and $125 million, reflecting confidence in future growth.
- Advanced Risk Selection Tools: The partnership provides Hippo access to advanced risk selection tools and analytics, enhancing underwriting capabilities and direct connections with reinsurance partners, thereby optimizing overall business operations.
- Strategic Development Direction: This collaboration not only continues the relationship established in 2025 but also represents a significant step in Hippo's strategy to diversify its portfolio through disciplined underwriting and continuous optimization, indicating ongoing expansion in the insurance market.
See More









